Taysha Gene Therapies Cash from Financing (TTM) Trends

Taysha Gene Therapies Inc (TSHA)

2.475 -0.14 (-5.53%) USD | NASDAQ | May 07, 16:00

2.39 -0.08 (-3.43%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
December 31, 2023	136.39M
September 30, 2023	181.87M
June 30, 2023	41.14M
March 31, 2023	51.83M
December 31, 2022	52.10M
September 30, 2022	19.97M
June 30, 2022	50.05M

Date	Value
March 31, 2022	38.98M
December 31, 2021	39.08M
September 30, 2021	28.50M
June 30, 2021	272.70M
March 31, 2021	273.04M
December 31, 2020	291.06M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

19.97M

Minimum

Sep 2022

291.06M

Maximum

Dec 2020

113.59M

Average

51.83M

Median

Mar 2023

Cash from Financing (TTM) Benchmarks